News
IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition marked by the accumulation of IgG4-positive plasma ...
Quantum BioPharma (QNTM) announced that the reconsideration motion by Dr. Raza Bokhari at the Court of Appeal, CoA, for Ontario was dismissed ...
Lina Manufacturing Limited, the pharmaceutical manufacturing arm of Sunshine Holdings PLC, unveiled its new brand identity – a powerful logo that reflects the company’s evolution, vision, and ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Avidity Biosciences (RNA – Research Report), ...
The partnership integrates advanced AI-driven analytics and clinical trial solutions, empowering biopharma companies to accelerate drug development and deliver targeted therapies faster. BETHESDA ...
The partnership integrates advanced AI-driven analytics and clinical trial solutions, empowering biopharma companies to accelerate ... Precision for Medicine is part of Precision Medicine Group, with ...
Analyses from Randomized Controlled Trials Further Support the Target Engagement and Safety Profile of Ampreloxetine in Neurodegenerative Disease< ...
Zenas BioPharma, Inc. ("Zenas” or the "Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed ...
Artis BioSolutions joins a host of startups trying to improve development and manufacturing capacity for cutting-edge gene ...
Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical ...
Cantor Fitzgerald issues an Overweight rating with a $7.00 price target Mereo BioPharma Group plc stands at a critical juncture, with significant potential upside balanced against the inherent risks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results